|
Monday, March 24 — 1:00 PM — Marriott Salon 1
Click on the numbers in parentheses to display abstracts.
Section A - HEMATOPATHOLOGY
Chaired by: Judith Ferry and Wing C.Chan
| 1:00 |
Loss of Heterozygosity on Chromosome 9p21 (p15, p16) and 17p13 (p53) in Enteropathy-Type T-Cell Lymphoma
(1126)
EC Obermann, TC Diss, MLP Camozzi, RA Hamoudi, PG Isaacson, MQ Du, A Dogan
University College London, London, United Kingdom; Ospedale Niguarda Ca'Granda, Milan, Italy
|
| 1:15 |
Cutaneous Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Type: A Multiparameter Study, Including Molecular Analyses for Borrelia Burgdorferi DNA and API2-MALT1 Fusion Transcripts
(1096)
BK Kim, H Inagaki, C Li, A Pandya, M Rabkin, SH Swerdlow
University of Pittsburgh School of Medicine and Rabkin Dermatopathology, Pittsburgh, PA; Nagoya City University Medical School, Nagoya, Japan; UT Southwestern Medical Center, Dallas, TX
|
| 1:30 |
Recurrent Genetic Imbalances in Primary Mediastinal B-Cell Lymphoma (PMBL) Detected by Microarray-Based Comparative Genomic Hybridization (A-CGH)
(1152)
M Skacel, T Ruffalo, E Tso, JD Pettay, D Kandil, RR Tubbs, B Pohlman, ED Hsi
Cleveland Clinic Foundation, Cleveland, OH; Vysis, Inc., Downer's Grove, IL
|
| 1:45 |
The New Classification System of Mastocytosis: One-Year Experience Using Major and Minor Histopathologic Criteria
(1078)
HP Horny, DM Menke, P Valent
Univ. of Lubeck, Germany; Mayo Clinic, Jacksonville, FL; Univ.of Vienna, Austria
|
| 2:00 |
Expression of PKC-Beta or Cyclin D2 Predicts for Inferior Survival in Diffuse Large B-Cell Lymphoma
(1071)
CP Hans, DD Weisenburger, TC Greiner, GT Cochran, X Pan, JC Lynch, LM Hock, P Aoun, JO Armitage, WC Chan
University of Nebraska Medical Center, Omaha, NE
|
| 2:15 |
Expression of CD40 in Diffuse Large B Cell Lymphoma Is Associated with Longer Overall Survival and Time to Treatment Failure: Possible Proapoptotic Role of CD40 Via Induction of Bax
(1166)
E Torlakovic, J Linderoth, M Jerkeman, E Cavallin-Stahl, S Kvaloy -Norwegian Radium Hosp, Oslo, Norway
Lund University Hospital, Lund, Sweden
|
| 2:30 |
Prognostic Markers in Adult, De Novo, Diffuse Large B-Cell Lymphomas; CD10, Bcl-6, Bcl-2 and BCL2/IGH
(1113)
RF McClure, WR Macon, ED Remstein, GW Dewald, TM Habermann, PJ Kurtin
Mayo Clinic, Rochester, MN
|
| 2:45 |
Diffuse Large B-Cell Lymphoma. Biological Prognosis Score Based on Tissue Microarrays
(1143)
AI Saez, MJ Artiga, A Perez, FI Camacho, A Diez, JF Garcia, M Fraga, R Bosch, MS Rodriguez, M Pollan, AJ Saez, MA Piris
University of Granada, Granada; Centro Nacional de Investigaciones Oncologicas, Madrid; Hospital Clinico de Santiago de Compostela, Santiago de Compostela, La Coruna; Hospital Verge de la Cinta de Tortosa, Tortosa, Tarragona; 12 Octubre Hospital, Madrid; National Center for Epidemiology, Carlos III Institute of Health, Madrid; University of Jaen, Jaen, Spain
|
| 3:00 |
RECESS, EXHIBITS, POSTER SESSION II
|
| 4:30 |
NATHAN KAUFMAN TIMELY TOPICS LECTURE
Dr. Irving L. Weissman
Stem Cell Biology: Past, Present and Future
Marriott Ballroom
|
|
|
